A lipoic acid-gamma linolenic acid conjugate is effective against multiple indices of experimental diabetic neuropathy

Diabetologia

Volumn 41, Issue 7, 1998, Pages 839-843

  Hounsom, L ^a   Horrobin, D F ^b   Tritschler, H ^c   Corder, R ^d   Tomlinson, D R ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b Scotia Pharmaceutical   (United Kingdom)

^c ASTA MEDICA AG   (Germany)

^d QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Alpha lipoic acid; Gamma linolenic acid; Nerve conduction; Nerve growth factor; Neuropeptide Y; Rat; Substance P

Indexed keywords

CRESOL; GAMMA LINOLENIC ACID; NERVE GROWTH FACTOR; NEUROPEPTIDE Y; SUBSTANCE P; THIOCTIC ACID;

ANIMAL MODEL; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DIABETIC NEUROPATHY; DRUG EFFECT; DRUG MECHANISM; DRUG MIXTURE; MALE; NERVE CONDUCTION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RAT; STREPTOZOCIN DIABETES; TREATMENT OUTCOME;

ANIMALS; ANTIOXIDANTS; BUTYLATED HYDROXYTOLUENE; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEUROPATHIES; GAMMA-LINOLENIC ACID; MALE; MOTOR NEURONS; NERVE GROWTH FACTORS; NEURAL CONDUCTION; NEURONS, AFFERENT; NEUROPEPTIDE Y; RATS; RATS, WISTAR; SCIATIC NERVE; SUBSTANCE P; THIOCTIC ACID;

EID: 0031810195     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001250050996     Document Type: Article

References (41)

1. Biessels GJ, Van Dam PS (1997) Diabetic neuropathy: pathogenesis and current treatment perspectives. Neurosci Res Commun 20: 1-10
2. Yagihashi S (1996) Pathology and pathogenetic mechanisms of diabetic neuropathy. Diabetes Metab Rev 11: 193-225
3. Dyck PJ, Giannini C (1996) Pathologic alterations in the diabetic neuropathies of humans: A review. J Neuropathol Exp Neurol 55: 1181-1193
4. Tesfaye S, Malik R, Ward JD (1994) Vascular factors in diabetic neuropathy. Diabetologia 37: 847-854
5. Williamson JR, Chang K, Frangos M et al. (1993) Hyperglycemic pseudohypoxia and diabetic complications. Diabetes 42: 801-813
6. Cameron NE, Cotter MA, Basso M, Hohman TC (1997) Comparison of the effects of inhibitors of aldose reductase and sorbitol dehydrogenase on neurovascular function, nerve conduction and tissue polyol pathway metabolites in streptozotocin-diabetic rats. Diabetologia 40: 271-281
7. Sasaki H, Schmelzer JD, Zollman PJ, Low PA (1997) Neuropathology and blood flow of nerve, spinal roots and dorsal root ganglia in longstanding diabetic rats. Acta Neuropathol (Berl) 93: 118-128
8. Kihara M, Low PA (1995) Impaired vasoreactivity to nitric oxide in experimental diabetic neuropathy. Exp Neurol 132: 180-185
9. Horrobin DF (1988) The roles of essential fatty acids in the development of diabetic neuropathy and other complications of diabetes mellitus. Prostaglandins Leukotrienes Essen Fatty Acids 31: 181-197
10. Tomlinson DR, Fernyhough P, Diemel LT (1997) Role of neurotrophins in diabetic neuropathy and treatment with nerve growth factors. Diabetes 46:S43-S49
11. Dyck PJ (1996) Nerve growth factor and diabetic neuropathy. Lancet 348: 1044-1045
12. Tomlinson DR, Fernyhough P, Diemel LT (1996) Neurotrophins and peripheral neuropathy. Philos Trans R Soc Lond B Biol Sci 351: 455-462
13. Thomas PK (1994) Growth factors and diabetic neuropathy. Diabet Med 11: 732-739
14. Maeda K, Fernyhough P Tomlinson DR (1997) Effects of treatment of diabetic rats with human recombinant nerve growth factor on sciatic nerve conduction, Doppler flux and substance P levels. Diabet Nutr Metab 10: 3-8
15. Robinson JP, Willars GB, Tomlinson DR, Keen P (1987) Axonal transport and tissue contents of substance P in rats with long-term streptozotocin-diabetes. Effects of the aldose reductase inhibitor 'statil'. Brain Res 426: 339-348
16. Tomlinson DR, Robinson JP, Compton AM, Keen P (1989) Essential fatty acid treatment-effects on nerve conduction, polyol pathway and axonal transport in streptozotocin diabetic rats. Diabetologia 32: 655-659
17. Packer L (1994) Antioxidant properties of lipoic acid and its therapeutic effects in prevention of diabetes complications and cataracts. Ann NY Acad Sci 738: 257-264
18. Nagamatsu M, Nickander KK, Schmelzer JD et al. (1995) Lipoic acid improves nerve blood flow, reduces oxidative stress, and improves distal nerve conduction in experimental diabetic neuropathy. Diabetes Care 18: 1160-1167
19. Garrett NE, Malcangio M, Dewhurst M, Tomlinson DR (1997) α-Lipoic acid corrects neuropeptide deficits in diabetic rats via induction of trophic support. Neurosci Lett 222: 191-194
20. Sharma AK, Thomas PK (1974) Peripheral nerve structure and function in experimental diabetes. J Neurol Sci 23: 1-15
21. Brewster WJ, Diemel LT, Leach RM, Tomlinson DR (1994) Reduced sciatic nerve substance P and calcitonin gene-related peptide in rats with short-term diabetes or central hypoxaemia coexist with normal messenger RNA levels in the lumbar dorsal root ganglia. Neuroscience 58: 323-330
22. Corder R, Lowry PJ (1985) An immunoradiometric assay for the measurement of neuropeptide Y in plasma. Peptides 6: 1195-1200
23. Fernyhough P, Diemel LT, Brewster WJ, Tomlinson DR (1994) Deficits in sciatic nerve neuropeptide content coincide with a reduction in target tissue nerve growth factor mRNA in streptozotocin-diabetic rats; effects of insulin treatment. Neuroscience 62: 337-344
24. Hellweg R, Hartung H-D (1990) Endogenous levels of nerve growth factor (NGF) are altered in experimental diabetes mellitus: a possible role for NGF in the pathogenesis of diabetic neuropathy. J Neurosci Res 26: 258-267
25. Apfel SC, Arezzo JC, Brownlee M, Federoff H, Kessler JA (1994) Nerve growth factor administration protects against experimental diabetic sensory neuropathy. Brain Res 634: 7-12
26. Diemel LT, Brewster WJ, Fernyhough P, Tomlinson DR (1994) Expression of neuropeptides in experimental diabetes; effects of treatment with nerve growth factor or brain-derived neurotrophic factor. Mol Brain Res 21: 171-175
27. Gilchrist CA, Morrison CF, Chapman KE, Harmar AJ (1991) Identification of nerve growth factor-responsive sequences within the 5 ' region of the bovine preprotachykinin gene. DNA Cell Biol 10: 743-749
28. Fernyhough P, Diemel LT, Hardy J, Brewster WJ, Mohiuddin L, Tomlinson DR (1995) Human recombinant nerve growth factor replaces deficient neurotrophic support in the diabetic rat. Eur J Neurosci 7: 1107-1110
29. Fernyhough P, Diemel LT, Brewster WJ, Tomlinson DR (1995) Altered neurotrophin mRNA in peripheral nerve and skeletal muscle of experimentally diabetic rats. J Neurochem 64: 1231-1237
30. 75LNTR protein in lumbar dorsal root ganglia. Mol Brain Res 51: 82-90
31. Lundberg JM, Terenius L, Hokfelt T et al. (1982) Neuropeptide Y (NPY)-like immunoreactivity in peripheral noradrenergic neurons and effects of NPY on sympathetic function. Acta Physiol Scand 116: 477-480
32. Tatemoto K, Carlquist M, Mutt V (1982) Neuropeptide Y - a novel brain peptide with structural similarities to peptide YY and pancreatic polypeptide. Nature 296: 659-660
33. Wakisaka S, Kajander KC, Bennett GJ (1991) Increased neuropeptide Y (NPY)-like immunoreactivity in rat sensory neurons following peripheral axotomy. Neurosci Lett 124: 200-203
34. Ohara S, Tantuwaya V, DiStefano PS, Schmidt RE (1995) Exogenous NT-3 mitigates the transganglionic neuropeptide Y response to sciatic nerve injury. Brain Res 699: 143-148
35. Verge VMK, Richardson PM, Wiesenfeld-Hallin Z, Hökfelt T (1995) Differential influence of nerve growth factor on neuropeptide expression in vivo: a novel role in peptide suppression in adult sensory neurons. J Neurosci 15: 2081-2096
36. Allen JM, Tischler AS, Lee YC, Bloom SR (1984) Neuropeptide Y (NPY) in PC12 phaeochromocytoma cultures: responses to dexamethasone and nerve growth factor. Neurosci Lett 46: 291-296
37. Higuchi H, Nakano K, Miki N (1992) Identification of NGF-response element in the rat neuropeptide Y gene and induction of the binding proteins. Biochem Biophys Res Commun 189: 1553-1560
38. Balbi D, Allen JM (1994) Role of protein kinase C in mediating NGF effect on neuropeptide Y expression in PC12 cells. Brain Res Mol Brain Res 23: 310-316
39. Zhang X, Wiesenfeld-Hallin Z, Hökfelt T (1994) Effect of peripheral axotomy on expression of neuropeptide Y receptor mRNA in rat lumbar dorsal root ganglia. Eur J Neurosci 6: 43-57
40. + pump in streptozotocin-diabetic rats. Br J Pharmacol 105: 355-360
41. Packer L, Witt EH, Tritschler HJ (1995) α-Lipoic acid as a biological antioxidant. Free Radic Biol Med 19: 227-250